| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/16/2005 | EP1505977A2 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes |
| 02/16/2005 | EP1505945A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 02/16/2005 | EP1240166B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases |
| 02/16/2005 | CN1582330A In-vitro micro-organs and uses realated thereto |
| 02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 02/16/2005 | CN1582161A Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 02/16/2005 | CN1582157A Rehydrating formulation |
| 02/16/2005 | CN1582152A composition of estrogen and other hormons with ascorbate, lysine, proline and other substances |
| 02/16/2005 | CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia |
| 02/16/2005 | CN1189465C Vitamin D3 analogs with bis C-20 side chains |
| 02/16/2005 | CN1189154C Fluoride dentifrices of enhanced efficacy |
| 02/15/2005 | CA2421026C Viral inhibition by n-docosanol |
| 02/10/2005 | WO2005012320A2 Novel lincomycin derivatives possessing antimicrobial activity |
| 02/10/2005 | WO2005011640A2 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof |
| 02/10/2005 | WO2005011619A2 Lung-expressed polypeptides |
| 02/10/2005 | WO2005011618A2 Methods for the treatment of male and female sexual dysfunction |
| 02/10/2005 | WO2005011617A2 Transmucosal dosage forms for brain-targeted steroid chemical delivery systems |
| 02/10/2005 | WO2005011615A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 02/10/2005 | WO2005011613A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 02/10/2005 | WO2005011612A2 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 02/10/2005 | WO2005011611A2 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | WO2005011610A2 Neurodegenerative protein aggregation inhibition methods and compounds |
| 02/10/2005 | WO2005011609A2 Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 02/10/2005 | WO2005011607A2 Treatment of cancers expressing p95 erbb2 |
| 02/10/2005 | WO2005011606A2 System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| 02/10/2005 | WO2005011601A2 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | WO2005011600A2 Sterile preparations of phospholipids and anti-inflammatory pharmaceuticals and methods for making and using same |
| 02/10/2005 | WO2005011599A2 Antibodies specific for toxic amyloid beta protein oligomers |
| 02/10/2005 | WO2005011598A2 Leukemia treatment method and composition |
| 02/10/2005 | WO2005011597A2 Compounds and compositions as protein kinase inhibitors |
| 02/10/2005 | WO2005011596A2 Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 02/10/2005 | WO2005011593A2 Improved binding of pantoprazole to the acid pump |
| 02/10/2005 | WO2005011592A2 Substituted indazole-o-glucosides |
| 02/10/2005 | WO2005011591A2 Method for the treatment of sleep disorders |
| 02/10/2005 | WO2005011590A2 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 02/10/2005 | WO2005011589A2 Drug delivery methods and devices |
| 02/10/2005 | WO2005011587A2 Chalaropsis lysozyme protein and its method of use in anti-bacterial applications |
| 02/10/2005 | WO2005011583A2 Treatment of allergic rhinitis and asthma |
| 02/10/2005 | WO2005011581A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | WO2005011580A2 Compositions and methods for herpes simplex prophylaxis and treatment |
| 02/10/2005 | WO2005011579A2 Treatment of dependence withdrawal |
| 02/10/2005 | WO2005011576A2 Digital chromatography |
| 02/10/2005 | WO2005011575A2 Stabilization and ionic triggering of nitric oxide release |
| 02/10/2005 | WO2005011574A2 Microporous membrane nebulizers |
| 02/10/2005 | WO2005011573A2 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 02/10/2005 | WO2005011572A2 Combination of drugs for the treatment of neoplasms |
| 02/10/2005 | WO2005011571A2 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 02/10/2005 | WO2005011569A2 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 02/10/2005 | WO2005011568A2 Process for extracting vital components from plants |
| 02/10/2005 | WO2004112716A3 Prodrugs of heteroaryl compounds |
| 02/10/2005 | WO2004112701A3 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | WO2004110354A3 Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis |
| 02/10/2005 | WO2004105696A3 Combination therapy for the treatment of neoplasms |
| 02/10/2005 | WO2004093824A3 Peri-operative and peri-procedure nutritional supplementation |
| 02/10/2005 | WO2004071465A3 Methods and kits for use in the diagnosis and treatment of endotoxemia |
| 02/10/2005 | WO2004062591A3 Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases |
| 02/10/2005 | WO2004060305A3 Anti-cancer medicaments |
| 02/10/2005 | WO2004058188A3 Vaccine compositions and methods |
| 02/10/2005 | WO2004054507A3 Indolizine compounds |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | US20050033127 Wireless blood glucose monitoring system |
| 02/10/2005 | US20050033076 Coordination polymerization catalysts |
| 02/10/2005 | US20050032886 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 02/10/2005 | US20050032857 Administering 3-(2-hydroxyethyl)-2-[2-[[3-(2-hydroxyethyl)-5-methoxy-2-benzothiazolylidene]methyl]-1-butenyl]-5-methoxybenzothiazolium derivative or salt to treat nervous system and brain disorders; Alzheimer*s disease |
| 02/10/2005 | US20050032856 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 02/10/2005 | US20050032835 Compositions and methods for inhibiting TGF-beta |
| 02/10/2005 | US20050032831 Histone deacetylase inhibitors and methods of use thereof |
| 02/10/2005 | US20050032808 Pyrazine carboxamide compounds for use in treatment of obesity, psychiatric and neurological disorders; for example, N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032782 Treatment of chronic pain associated with drug or radiation therapy |
| 02/10/2005 | US20050032780 Method of treating functional bowel disorders |
| 02/10/2005 | US20050032750 Treating androgen deficiency in female (ADIF)-associated conditions with SARMS |
| 02/10/2005 | US20050032747 Cyclooxygenase-2 and Fatty Acid Amide Hydrolase; substituted N-benzoyl-5-((alkyl carbonyl, alkyloxycarbonyl, alkylaminocarbonyl or alkylphosphonato)oxy)indoles; analgesics, antiinflammatory and anxiolytic agents |
| 02/10/2005 | US20050032739 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 02/10/2005 | US20050032725 useful in the diagnosis, treatment or prevention of conditions characterized by a too-vigorous effector T cell response to antigens |
| 02/10/2005 | US20050032711 Antidiabetic agents; insulin resistance |
| 02/10/2005 | US20050032660 Storing a composition in an alcoholic gel |
| 02/10/2005 | US20050032138 Using monoclonal antobody to identify presence of prion protein in bodily fluids; immunodiagnostics and detection of spongiform encephalopathies |
| 02/10/2005 | US20050031709 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 02/10/2005 | US20050031700 In the form of a powder for suspension containing (a) an acid-labile proton pump inhibitor in micronized from; b) an antacid; and c) a gum as suspending agent |
| 02/10/2005 | US20050031646 Immunogens; polysaccharide conjugate antigens derived from pathogenic bacterium conjugated to protein D from Haemophilus influenzae |
| 02/10/2005 | US20050031615 For treating proliferative diseases characterized by neovascularization such as cancer, rheumatoid arthritis, psoriasis, proliferative retinopathy, and/or macular degeneration; rapid prevention of blood clotting via the extrinsic pathway; angiogenesis inhibitors |
| 02/10/2005 | US20050031607 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 02/10/2005 | US20050031606 Lyase treatment for P. carinii |
| 02/10/2005 | US20050031605 Compositions and methods of treating diabetes |
| 02/10/2005 | US20050031593 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 02/10/2005 | CA2549017A1 Substituted indazole-o-glucosides |
| 02/10/2005 | CA2534354A1 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 02/10/2005 | CA2533893A1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | CA2533824A1 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | CA2533774A1 Compounds and compositions as protein kinase inhibitors |
| 02/10/2005 | CA2533554A1 6-membered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | CA2533129A1 System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| 02/10/2005 | CA2529954A1 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 02/10/2005 | CA2529521A1 Combination of drugs for the treatment of neoplasms |
| 02/10/2005 | CA2528592A1 Novel lincomycin derivatives possessing antimicrobial activity |
| 02/09/2005 | EP1505499A1 Automatic detection and patching of vulnerable files |
| 02/09/2005 | EP1504252A1 Systems and methods for blood glucose sensing |
| 02/09/2005 | EP1504019A1 Platinum complexes having antitumor activity |
| 02/09/2005 | EP1503794A1 Methods of treatement using ctla-4 antibodies |